CA2054870A1 - Derives a proprietes antivirales de (phosphonomethoxy) methoxypurine/pyrimidine - Google Patents

Derives a proprietes antivirales de (phosphonomethoxy) methoxypurine/pyrimidine

Info

Publication number
CA2054870A1
CA2054870A1 CA2054870A CA2054870A CA2054870A1 CA 2054870 A1 CA2054870 A1 CA 2054870A1 CA 2054870 A CA2054870 A CA 2054870A CA 2054870 A CA2054870 A CA 2054870A CA 2054870 A1 CA2054870 A1 CA 2054870A1
Authority
CA
Canada
Prior art keywords
phosphonomethoxy
pyrimidine derivatives
antiviral
purine
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2054870A
Other languages
English (en)
Other versions
CA2054870C (fr
Inventor
Choung Un Kim
John C. Martin
Bing Yu Luh
Peter F. Misco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stichting Rega VZW
Institute of Organic Chemistry and Biochemistry CAS
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CA2054870A1 publication Critical patent/CA2054870A1/fr
Application granted granted Critical
Publication of CA2054870C publication Critical patent/CA2054870C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA002054870A 1990-11-29 1991-11-04 Derives a proprietes antivirales de (phosphonomethoxy) methoxypurine/pyrimidine Expired - Lifetime CA2054870C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/619,856 US5208221A (en) 1990-11-29 1990-11-29 Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives
US619,856 1990-11-29

Publications (2)

Publication Number Publication Date
CA2054870A1 true CA2054870A1 (fr) 1992-05-30
CA2054870C CA2054870C (fr) 1995-08-29

Family

ID=24483605

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002054870A Expired - Lifetime CA2054870C (fr) 1990-11-29 1991-11-04 Derives a proprietes antivirales de (phosphonomethoxy) methoxypurine/pyrimidine

Country Status (8)

Country Link
US (2) US5208221A (fr)
EP (1) EP0494370B1 (fr)
JP (1) JP3172803B2 (fr)
AT (1) ATE124412T1 (fr)
CA (1) CA2054870C (fr)
DE (1) DE69110854T2 (fr)
DK (1) DK0494370T3 (fr)
ES (1) ES2074637T3 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208221A (en) * 1990-11-29 1993-05-04 Bristol-Myers Squibb Company Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives
CA2171868A1 (fr) * 1993-09-17 1995-03-23 Petr Alexander Methode pour le dosage de composes therapeutiques
US5656745A (en) * 1993-09-17 1997-08-12 Gilead Sciences, Inc. Nucleotide analogs
US5798340A (en) * 1993-09-17 1998-08-25 Gilead Sciences, Inc. Nucleotide analogs
US5502177A (en) 1993-09-17 1996-03-26 Gilead Sciences, Inc. Pyrimidine derivatives for labeled binding partners
US5977061A (en) * 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use
US5969135A (en) * 1995-11-02 1999-10-19 Icn Pharmaceuticals, Inc. Oligonucleotide analogs with an amino acid or a modified amino alcohol residue
US6093816A (en) 1996-06-27 2000-07-25 Isis Pharmaceuticals, Inc. Cationic lipids
US5922695A (en) * 1996-07-26 1999-07-13 Gilead Sciences, Inc. Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
US6765019B1 (en) 1999-05-06 2004-07-20 University Of Kentucky Research Foundation Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
IL150594A0 (en) * 2000-01-07 2003-02-12 Ustav Ex Botan Adademie Ved Ce Purine derivatives, process for their preparation and use
US20020119443A1 (en) * 2000-07-21 2002-08-29 Gilead Sciences, Inc. Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
EP1406911B1 (fr) 2001-06-29 2016-01-06 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Dérivés de 6-[2-(phosphonomethoxy)alkoxy] pyrimidine et leur activité antivirale
US20040023928A1 (en) * 2001-10-31 2004-02-05 Colacino Joseph Matthew Phosphonate nucleotide and thiadiazole compounds for the treatment of smallpox
US7247621B2 (en) * 2002-04-30 2007-07-24 Valeant Research & Development Antiviral phosphonate compounds and methods therefor
DK1583542T3 (da) 2003-01-14 2008-09-22 Gilead Sciences Inc Sammensætninger og fremgangsmåder til antiviral kombinationsterapi
NZ543864A (en) 2003-06-16 2009-10-30 Leuven K U Res & Dev Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
EP1906971A2 (fr) * 2005-07-27 2008-04-09 Gilead Sciences, Inc. Composes antiviraux
TWI444384B (zh) 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
CN114588161A (zh) * 2020-12-07 2022-06-07 四川大学华西医院 具有防治肺炎作用的次黄碱衍生物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868187A (en) * 1980-09-16 1989-09-19 Syntex (U.S.A.) Inc. Anti-viral N-substituted pyrimidines
DE3277837D1 (en) * 1982-08-06 1988-01-28 Engineering Ind Inc Emulsion package and method of mixing the emulsion
CS233665B1 (en) * 1983-01-06 1985-03-14 Antonin Holy Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene
CS263951B1 (en) * 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
DE3689263T2 (de) * 1985-11-25 1994-04-28 Alcatel Nv Telemetrie-endstation.
CS264222B1 (en) * 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
NZ222553A (en) * 1986-11-18 1991-07-26 Bristol Myers Co Phosphonomethoxyalkylene purine and pyrimidine derivatives and pharmaceutical compositions
WO1988005438A1 (fr) * 1987-01-20 1988-07-28 Sri International Agents antiviraux
DE3721959A1 (de) * 1987-07-03 1989-01-19 Mannesmann Kienzle Gmbh Geber fuer den betriebszustand von bremsen
IL88518A (en) * 1987-11-30 1994-02-27 Beecham Group Plc 3-(phosphoryl methoxyethoxy) -purine derivatives, their preparation and pharmaceutical compositions containing them
EP0338168A1 (fr) * 1988-04-19 1989-10-25 Merrell Dow Pharmaceuticals Inc. Dérivés de la phosphonoalkyl purine
SE8801729D0 (sv) * 1988-05-06 1988-05-06 Astra Ab Purine derivatives for use in therapy
US4952707A (en) * 1988-06-30 1990-08-28 Tropix, Inc. Enzymatically-cleavable chemiluminescent fused polycyclic ring-containing 1,2-dioxetanes
EP0353955A3 (fr) * 1988-08-02 1991-08-14 Beecham Group Plc Composés chimiques
GB8907173D0 (en) * 1989-03-30 1989-05-10 Beecham Group Plc Novel compounds
US4988703A (en) * 1989-05-22 1991-01-29 Abbott Laboratories Carbocyclic nucleoside analogs with antiviral activity
GB8912043D0 (en) * 1989-05-25 1989-07-12 Beecham Group Plc Novel compounds
US5208221A (en) * 1990-11-29 1993-05-04 Bristol-Myers Squibb Company Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives

Also Published As

Publication number Publication date
ES2074637T3 (es) 1995-09-16
JPH04266893A (ja) 1992-09-22
US5208221A (en) 1993-05-04
DE69110854D1 (de) 1995-08-03
DE69110854T2 (de) 1995-12-07
EP0494370A1 (fr) 1992-07-15
US5386030A (en) 1995-01-31
ATE124412T1 (de) 1995-07-15
DK0494370T3 (da) 1995-08-28
EP0494370B1 (fr) 1995-06-28
JP3172803B2 (ja) 2001-06-04
CA2054870C (fr) 1995-08-29

Similar Documents

Publication Publication Date Title
CA2054870A1 (fr) Derives a proprietes antivirales de (phosphonomethoxy) methoxypurine/pyrimidine
IL89796A0 (en) Bis-(hydroxymethyl)cyclobutyl purine and pyrimidine derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof
AU1261488A (en) Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
AU7941491A (en) 9-purinyl phosphonic acid derivatives
CY2186B1 (en) Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
AU7855191A (en) 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents
EP0409227A3 (en) Pyrimidine and purine nucleosides, their preparation and use as medicaments
EP0515107A3 (en) Azolo (1,3,5) triazines as adenosine antagonists
GR3036577T3 (en) Novel carbocyclic adenosine analogs useful as immunosuppressants.
ZA901993B (en) Antiviral compositions
AP9000166A0 (en) Antiviral tetrahydroimidazol(1.4)benzodiazepin-2-thiones
DK630589D0 (da) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor-sammensaetning
AU633065B2 (en) 3'-substituted methyl nucleosides as antiviral agents
FI944933L (fi) 7-disubstitoitu metyyli-4-okso-3H,5H-pyrrolo(3,2-d) pyrimidiini ja sitä sisältäviä farmaseuttisia käyttöjä ja koostumuksia
NZ220871A (en) 5,6,7,8-tetrahydropyrido(2,3-d)pyrimidine derivatives and pharmaceutical compositions
AU7273187A (en) Diastereoisomeric tetrahydropyrido (2,3-d) pyrimidine derivatives
AU564194B2 (en) 9 - substituted guanines as antiviral agents
EP0515108A3 (en) Azolo (1,3,5) triazines as adenosine antagonists
AU1699992A (en) Dibenzothiazepinthione as antiviral agents
SG42292G (en) Antiviral composition comprising isopropyldeoxyuridine
GB9116030D0 (en) Antiviral compositions
IL88854A0 (en) Pyrimidine and purine 1,2-butadiene-4-ol derivatives and pharmaceutical compositions containing the same
IL93001A0 (en) Purine nucleosides and nucleotides,processes for the preparation thereof and pharmaceutical compositions containing the same
GB9506644D0 (en) Preparation of nucleoside analogues
EP0477871A3 (en) Antiviral composition, containing guanine derivatives

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry